Institution: | 1. Section of Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom.; 2. Bioinformatics Group, Institute of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.; 3. Haematological Malignancy Diagnostic Service (HMDS), St. James’s Institute of Oncology, Leeds, United Kingdom.; University of North Carolina at Chapel Hill, United States of America, |